Xing L, Jing L, Tian Y, et al. High prevalence of stroke and uncontrolled associated risk factors are major public health challenges in rural northeast China: a population-based study. Int J Stroke 2019.
2.
Mead GE, Legg L, Tilney R, et al. Fluoxetine for stroke recovery: meta-analysis of randomized controlled trials. Int J Stroke 2019.
3.
FOCUS Trial Collaboration. Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial. Lancet2019; 389: 265–274.
4.
Markus HS and Brainin M. COVID-19 and stroke --A global World Stroke Organization perspective. Int J Stroke 2020; 15(4): 361–364.
5.
Aggarwal G, Lippi G and Michael Henry B. Cerebrovascular disease is associated with an increased disease severity in patients with Coronavirus Disease 2019 (COVID-19): A pooled analysis of published literature. Int J Stroke 2020; 15(4); 385–389.
6.
Qureshi A, Abd-Allah F, Al-Senani FM, et al. Management of Acute Ischemic Stroke in Patients with COVID-19 Infection: Report of an International Panel. Int J Stroke. Epub ahead of print 3 May 2020. DOI: 10.1177/1747493020923234.
